High density lipoproteinuria in nephrotic syndrome

Area of Science:

• Nephrology
• Lipid Metabolism
• Experimental Pathology

Background:

• Puromycin aminonucleoside-induced nephrotic syndrome in rats mimics human disease.
• Nephrotic syndrome is characterized by proteinuria, hypercholesterolemia, hypoproteinemia, and edema.
• Understanding urinary lipoprotein changes is crucial for elucidating nephrotic syndrome pathophysiology.

Purpose of the Study:

• To characterize urinary lipoproteins in nephrotic rats.
• To investigate the urinary loss of apolipoproteins that activate lipoprotein lipase.
• To assess the functional properties of excreted urinary lipoproteins.

Main Methods:

• Induction of nephrotic syndrome in Sprague-Dawley rats using puromycin aminonucleoside.
• Collection and ultracentrifugation of plasma and urine to isolate lipoprotein fractions (VLDL, LDL, HDL).
• Analysis of lipoprotein composition (cholesterol, triglyceride, phospholipid, protein) and electrophoretic mobility.
• In vitro assay measuring free fatty acid liberation by lipoprotein lipase to assess activator properties.

Main Results:

• Measurable urinary lipoproteins were detected 7 and 18 days post-induction.
• Urinary lipoproteins exhibited alpha-electrophoretic mobility, characteristic of HDL.
• Urinary HDL had higher protein content compared to plasma HDL, with increasing protein over time.
• Nephrotic rat urine significantly enhanced lipoprotein lipase activity compared to control urine.

Conclusions:

• High-density lipoproteins are likely excreted via glomerular filtration in this nephrotic rat model.
• Excreted lipoproteins may undergo compositional alterations during passage through the nephron.
• Urinary loss of functionally important HDL may contribute to hyperlipoproteinemia in nephrotic syndrome.